emia,9 suggest that subclass pattern B represents the phenotypic expression of a single genetic locus with a dominant or additive mode of inheritance and incomplete penetrance in premenopausal women and men below age 20 years. Recently, evidence for linkage between LDL subclass phenotype B and the LDL receptor locus on chromosome 19 has been presented. 10 The presence of small, dense LDL or phenotype B is associated with a lipid profile that includes higher levels of plasma triglycerides, very low-density lipoprotein (VLDL) mass, and apolipoprotein B and lower levels of high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I.9'11'12 For this reason, the LDL subclass phenotype has been designated the atherogenic lipoprotein phenotype (ALP).10'12 The syndrome of insulin resistance,13 or syndrome X,14 features a very similar dyslipidemia and a cluster of other coronary heart disease risk factors including obesity, central body fat distribution, hypertension, and glucose intolerance. This and the association of small, dense LDL with NIDDM suggest that LDL particle diameter and LDL subclass phenotype B may be related to hyperinsulinemia or insulin resistance. Moreover, the relations of phenotype B with other component risk factors of the insulin resistance syndrome are of interest and potentially of clinical importance.
In the present report, we examine cross-sectional associations of LDL subclass phenotypes with fasting and post-glucose load insulin levels and with other coronary heart disease risk factors that have been related to insulin resistance in a large sample of adult female twins. The availability of identical twin pairs who were discordant for LDL subclass phenotype allows us to determine whether IGT, impaired glucose tolerance.
The peak particle diameter of the major LDL subclass was also examined as a continuous dependent variable to determine whether associations noted with LDL subclass phenotype were also seen with particle diameter. Both generalized least squares methods and the generalized estimating equations require complete data for both twins of each pair. Thus, if either twin was missing data for any variable in the models, that pair was excluded from all analyses. The only variables missing in more than three pairs were postload glucose and insulin levels, missing for at least one twin in 12 pairs. Exclusion of a total of 15 pairs left 564 women in whom multivariate models were examined.
There were 25 nondiabetic MZ twin pairs who were discordant for phenotype B using the broad definition (phenotype I's treated as phenotype B's). To study associations of LDL subclass phenotype and risk factors independent of genetic variation, we examined mean intrapair risk factor differences for these 25 pairs. Since MZ twins are genetically identical, all intrapair differences for both phenotype and risk factor levels must be due to nongenetic factors. If associations of phenotype with other variables persist in these analyses, these associations are also due to nongenetic sources of variation in the variables (ie, behavioral, environmental, or random effects). Intrapair differences for each risk factor were obtained by subtracting its value in the twin with phenotype B from that of the sister with phenotype A. Associations of risk factors with peak LDL particle diameter were also evaluated using matched multiple linear regression models that included all 176 nondiabetic MZ twin pairs. In these analyses, the intrapair difference in peak particle diameter was regressed on intrapair differences in risk factors.
Results
The prevalence of phenotype B and the intermediate phenotype I were 10.4% and 10.9%, respectively, in the entire sample. The prevalence of both phenotypes B and I increased with age through the seventh decade ( Figure, graph a) In multivariate models using the broad definition of LDL subclass phenotype as the outcome variable, we examined whether associations of waist-hip ratio and systolic blood pressure with phenotype were independent of the associations of phenotype with HDL and triglyceride levels ( Table 2) . Neither increasing age nor body mass index were predictive of subclass B once waist-hip ratio was included in the model (model 1). With HDL cholesterol and triglyceride levels added to the model, associations of waist-hip ratio and systolic blood pressure persisted, although the magnitude of the regression coefficient for waist-hip ratio was diminished (model 2). In a third model, fasting insulin and glucose were included to assess whether insulinemia or glucose To verify findings of the multivariate model, we grouped nondiabetic women by the number of manifestations of the insulin resistance syndrome they demonstrated. For purposes of this categorization, plasma triglycerides, HDL cholesterol, fasting insulin, systolic blood pressure, and waist-hip ratio were dichotomized, with values more extreme than the following cutoffs considered consistent with the insulin resistance syndrome: triglycerides >250 mg/dL, HDL cholesterol <45 mg/dL, fasting insulin above the 75th percentile of the sample distribution (or >14.0 ,uU/mL), systolic blood pressure > 160 mm Hg or current pharmaceutical treatment of hypertension, and waist-hip ratio above the 75th percentile of the sample distribution (or >0.824). Consistent with the model, the prevalence of phenotype B (broad definition) rose progressively (Table 3) With the exception of systolic blood pressure, similar findings were noted in a model that substituted LDL peak particle diameter, a continuous variable, for LDL subclass phenotype. Using multiple linear regression and including all variables from model 3 of Table 2 , significant inverse associations with particle diameter were observed for triglyceride level, waist-hip ratio, and fasting insulin level; a strong positive association was seen for HDL cholesterol level. Systolic blood pressure was not a significant independent predictor of particle diameter in this model (j3= -0.01, P=.24). When 78 pairs in which one or both twins were taking antihypertensive medications were removed, the coefficient estimate was somewhat larger (1= -0.02) although still not statistically significant (P=.15).
To determine whether these associations persisted after removing all genetic variation, mean intrapair differences were examined for each variable in the 25 nondiabetic MZ twin pairs discordant for LDL subclass phenotype B, using the broad definition (Table 4) . Each manifestation of the insulin resistance syndrome was more apparent in the twin with phenotype B. Significantly higher mean plasma triglycerides and lower mean HDL cholesterol levels were found in the women with phenotype B than in their genetically identical sisters. Twins with pattern B were significantly more obese and had the higher waist-hip ratio and systolic blood pressure. The difference in postload insulin levels was quantitatively quite large, although it was of only borderline significance in this very small sample.
Similarly, in matched multiple linear regression analyses using all 176 nondiabetic MZ twin pairs, components of the insulin resistance syndrome remained as strongly related to LDL peak particle diameter as in the unmatched regression analysis. That is, nongenetic differences in waist-hip ratio (P<.0001), triglycerides (P<.0001), and fasting insulin (P=.0002) were independently and inversely related to intrapair differences in peak particle diameter. In the same model, differences in HDL cholesterol were positively associated with particle diameter (P=.002). As in the unmatched model, systolic blood pressure was unrelated to LDL peak particle diameter. Persons with phenotype B were more obese than those with phenotype A, but adjustment for obesity, as measured by body mass index, did not substantially diminish any of the cross-sectional associations with other risk factors. Body mass index was no longer predictive of subclass phenotype (P=.56) once waist-hip ratio was included in the regression models, emphasizing the predominant importance of central obesity. A strong association of waist-hip ratio with LDL particle diameter has been reported previously in a clinical study in men. 22 To our knowledge, a relation of LDL subclass phenotype or particle diameter with blood pressure level has not been previously reported. This association was also quite strong and was not diminished by adjustment for either lipid or insulin levels. A specific association of /3-blocker medication with small, dense LDL has been noted,23 but adjustment for use of 13-blockers in this study did not diminish the blood pressure/LDL subclass association. Many previous reports have noted the co-occurrence of hypertension with low HDL cholesterol and elevated triglyceride levels.24-26 The label "familial dyslipidemic hypertension" has been proposed to describe this association. 25 The present data suggest that LDL subclass phenotype B is an integral part of dyslipidemic hypertension.
We could not demonstrate a significant, independent, linear association of blood pressure level and LDL particle diameter. This discrepancy may result, at least in part, from the combined measurement errors for blood pressure level and LDL particle diameter. The increase in the magnitude of the coefficient with removal of persons using antihypertensive medications supports this explanation. An alternative explanation would be the presence of a nonlinear or threshold relation between blood pressure and LDL particle diameter.
The very strong association of LDL subclass phenotype B with impaired glucose tolerance and NIDDM in this study is consistent with the report of Barakat et Genetic influence on LDL subclass phenotypes or on LDL particle size has been demonstrated in this twin sample,27 in a large study of male twins,28 and in family studies.8'9 However, in each study, genetic factors appeared to explain no more than 50% of the variation in LDL particle size. Moreover, substantial discordance was noted for subclass phenotype B among identical twin pairs in this study. Twenty-five of the 40 nondiabetic MZ pairs in which at least one twin had phenotype B were discordant for the phenotype.
Previous reports have shown potentially beneficial effects of weight reduction7 and increased physical activity29 in increasing LDL Taken as a whole, the available information suggests that LDL subclass phenotype B is an integral part of the cluster of risk factors that has been termed the insulinresistance syndrome14 or syndrome X. 13 However, none of the associations appeared to be accounted for by the level of insulinemia. Neither the previously reported associations of subclass phenotype with triglyceride and HDL cholesterol levels nor the strong independent associations with central obesity and blood pressure level were diminished by adjusting for insulin levels. Perhaps some aspect of insulin resistance not directly measured by plasma insulin levels may explain the associations. However, it is also possible that hyperinsulinemia is primarily a marker for this syndrome30 in which the primary abnormality could be a defect in lipid metabolism.3'
